Crosstalk between adipokines and myokines in fat browning

Abstract Skeletal muscle is the largest organ determining whole‐body insulin sensitivity and metabolic homoeostasis. Adaptive changes of skeletal muscle in response to physical activity include adjustments in the production and secretion of muscle‐derived bioactive factors, known as myokines, such as myostatin, IL ‐4, IL ‐6, IL ‐7 and IL ‐15, myonectin, follistatin‐like 1 or leukaemia inhibitory factor. These myokines not only act locally in the muscle in an autocrine/paracrine manner, but also are released to the bloodstream as endocrine factors to regulate physiological processes in other tissues. Irisin, derived from the cleavage of FNDC 5 protein, constitutes a myokine that induces myogenesis and fat browning (switch of white adipocytes to brown fat‐like cells) together with a concomitant increase in energy expenditure. Besides being a target for irisin actions, the adipose tissue also constitutes a production site of FNDC 5. Interestingly, irisin secretion from subcutaneous and visceral fat depots is decreased by long‐term exercise training and fasting, suggesting a discordant regulation of FNDC 5/irisin in skeletal muscle and adipose tissue. Accordingly, our group has recently reported that the adipokine leptin differentially regulates FNDC 5/irisin expression in skeletal muscle and fat, confirming the crosstalk between both tissues. Moreover, irisin secretion and function are regulated by other myokines, such as follistatin or myostatin, as well as by other adipokines, including fibroblast growth factor 21 and leptin. Taken together, myokines have emerged as novel molecular mediators of fat browning and their activity can be modulated by adipokines, confirming the crosstalk between skeletal muscle and adipose tissue to regulate thermogenesis and energy expenditure.